Pacific Center for Financial Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $33.2K | Hold |
175
| – | – | 0.01% | 232 |
|
|
2026
Q1 | $34.5K | Hold |
175
| – | – | 0.01% | 222 |
|
|
2025
Q4 | $26.9K | Hold |
175
| – | – | 0.01% | 246 |
|
|
2025
Q3 | $26.9K | Hold |
175
| – | – | 0.01% | 246 |
|
|
2025
Q2 | $24.5K | Hold |
175
| – | – | 0.01% | 241 |
|
|
2025
Q1 | $25.7K | Hold |
175
| – | – | 0.01% | 235 |
|
|
2024
Q4 | $22.9K | Hold |
175
| – | – | 0.01% | 248 |
|
|
2024
Q3 | $27.3K | Hold |
175
| – | – | 0.01% | 230 |
|
|
2024
Q2 | $27.3K | Hold |
175
| – | – | 0.01% | 223 |
|
|
2024
Q1 | $23.7K | Hold |
175
| – | – | 0.01% | 233 |
|
|
2023
Q4 | $23.6K | Hold |
175
| – | – | 0.01% | 221 |
|
|
2023
Q3 | $23.7K | Hold |
175
| – | – | 0.01% | 221 |
|
|
2023
Q2 | $25.1K | Hold |
175
| – | – | 0.01% | 208 |
|
|
2023
Q1 | $24.3K | Buy |
+175
| New | +$23.5K | 0.01% | 210 |
|
|
2022
Q3 | $19K | Hold |
175
| – | – | 0.01% | 229 |
|
|
2022
Q2 | $23K | Hold |
175
| – | – | 0.01% | 206 |
|
|
2022
Q1 | $23K | Hold |
175
| – | – | 0.01% | 221 |
|
|
2021
Q4 | $20K | Hold |
175
| – | – | 0.01% | 234 |
|
|
2021
Q3 | $21K | Hold |
175
| – | – | 0.01% | 225 |
|
|
2021
Q2 | $21K | Hold |
175
| – | – | 0.01% | 217 |
|
|
2021
Q1 | $17K | Hold |
175
| – | – | 0.01% | 224 |
|
|
2020
Q4 | $17K | Hold |
175
| – | – | 0.01% | 217 |
|
|
2020
Q3 | $19K | Hold |
175
| – | – | 0.01% | 179 |
|
|
2020
Q2 | $19K | Hold |
175
| – | – | 0.01% | 172 |
|
|
2020
Q1 | $16K | Hold |
175
| – | – | 0.01% | 164 |
|
|
2019
Q4 | $17K | Hold |
175
| – | – | 0.01% | 181 |
|
|
2019
Q3 | $16K | Hold |
175
| – | – | 0.01% | 186 |
|
|
2019
Q2 | $14K | Hold |
175
| – | – | 0.01% | 191 |
|
|
2019
Q1 | $14K | Hold |
175
| – | – | 0.01% | 186 |
|
|
2018
Q4 | $13K | Hold |
175
| – | – | 0.01% | 194 |
|
|
2018
Q3 | $14K | Hold |
175
| – | – | 0.01% | 192 |
|
|
2018
Q2 | $12K | Hold |
175
| – | – | 0.01% | 190 |
|
|
2018
Q1 | $12K | Hold |
175
| – | – | 0.01% | 187 |
|
|
2017
Q4 | $12K | Hold |
175
| – | – | 0.01% | 185 |
|
|
2017
Q3 | $12K | Hold |
175
| – | – | 0.01% | 181 |
|
|
2017
Q2 | $12K | Hold |
175
| – | – | 0.01% | 175 |
|
|
2017
Q1 | $11K | Hold |
175
| – | – | 0.01% | 175 |
|
|
2016
Q4 | $10K | Buy |
+175
| New | +$9.94K | 0.01% | 184 |
|
Other funds holding AZN
EP
IA
Pacific Center for Financial Services's AZN Position: Q2 2026 in Review
Pacific Center for Financial Services held its AstraZeneca (AZN) position steady in Q2 2026 at 175 shares worth $33.2K. The position accounts for 0.01% of the portfolio, ranked #232.
Pacific Center for Financial Services first reported a position in AZN in Q4 2016 and has held it in 38 quarters since. The position peaked at $34.5K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Pacific Center for Financial Services held 175 shares of AstraZeneca worth $33.2K as of Q2 2026.
- Pacific Center for Financial Services left its AstraZeneca share count unchanged in Q2 2026.
- AstraZeneca made up 0.01% of Pacific Center for Financial Services's portfolio in Q2 2026, its #232 holding.
- Pacific Center for Financial Services first reported a position in AstraZeneca in Q4 2016 and has held it in 38 quarters since.
- Pacific Center for Financial Services's AstraZeneca position peaked at $34.5K in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Pacific Center for Financial Services's 13F filing for Q2 2026, filed 5 Aug 2026.